CareDx, Inc ( CDNA) - Key Metrics
CDNA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.56 | $2.15 | $0.59 | $0.56 |
| 2026Q1 | $2.30 | $0.05 | $0.08 | $0.01 |
| 2025Q4 | $2.12 | -$0.08 | $0.42 | $0.39 |
| 2025Q3 | $1.91 | $0.03 | $0.71 | $0.69 |
| 2025Q2 | $1.60 | -$0.16 | $0.18 | $0.16 |
CDNA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 3.31 |
| 2026Q1 | 0% | 86.80 |
| 2025Q4 | 0% | -58.88 |
| 2025Q3 | 0% | 113.95 |
| 2025Q2 | 0% | -30.53 |
CDNA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.96% | 0% |
| 2026Q1 | 0.06% | 0% |
| 2025Q4 | 2.05% | 0% |
| 2025Q3 | 4.72% | 0% |
| 2025Q2 | 0.84% | 0% |
CDNA
Price: $50.88
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.05 USD
P/E Ratio: 22.97
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 944000
Ebitda: -11.9 millionMarket Capitalization: 2.6 billion